Armata Pharmaceuticals (ARMP) Accounts Payables (2013 - 2026)
Armata Pharmaceuticals (ARMP) posted Accounts Payables of $660000.0 for Q1 2026, down 61.29% sequentially from $1.7 million in Q4 2025, and down 32.72% YoY from $981000.0 in Q1 2025.
Armata Pharmaceuticals (ARMP) Accounts Payables (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has reported Accounts Payables for 14 years, with the latest figure at $660000.0 in Q1 2026.
- Quarterly Accounts Payables fell 32.72% year-over-year to $660000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $660000.0 (down 32.72% YoY) and the FY2025 annual result came in at $1.7 million, down 17.03% from the prior year.
- Accounts Payables fell to $660000.0 in Q1 2026 per ARMP's latest filing, from $1.7 million in the prior quarter.
- Over five years, Accounts Payables peaked at $9.6 million in Q2 2023 and troughed at $332000.0 in Q3 2024.
- A 5-year average of $3.0 million and a median of $2.1 million in 2024 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2023 and 2024: Accounts Payables jumped 138.35% in 2023, then plunged 95.04% in 2024.
- Over 5 years, Accounts Payables stood at $1.7 million in 2022, then decreased by 5.54% to $1.6 million in 2023, then gained by 29.65% to $2.1 million in 2024, then fell by 17.03% to $1.7 million in 2025, then sank by 61.29% to $660000.0 in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $660000.0, $1.7 million, and $582000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Armata Pharmaceuticals | 182.82 Mn | 158.82 Mn | - | 1.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.86 Mn |
| Mar 31, 2026 | 660,000.00 |
| Dec 31, 2025 | 1.71 Mn |
| Sep 30, 2025 | 582,000.00 |
| Jun 30, 2025 | 1.54 Mn |
| Mar 31, 2025 | 981,000.00 |
| Dec 31, 2024 | 2.06 Mn |
| Sep 30, 2024 | 332,000.00 |
| Jun 30, 2024 | 3.85 Mn |
| Mar 31, 2024 | 4.61 Mn |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 6.70 Mn |
| Jun 30, 2023 | 9.58 Mn |
| Mar 31, 2023 | 5.00 Mn |
| Dec 31, 2022 | 1.68 Mn |
| Sep 30, 2022 | 2.98 Mn |
| Jun 30, 2022 | 4.02 Mn |
| Mar 31, 2022 | 3.44 Mn |
| Dec 31, 2021 | 2.27 Mn |
| Sep 30, 2021 | 1.81 Mn |